Latest Leadership News

Page 252 of 398
JB Hi-Fi reported a robust FY25 with 10% sales growth and increased dividends, while preparing for a leadership change.
Logan Eniac
Logan Eniac
11 Aug 2025
JB Hi-Fi Limited reported a robust FY2025 with revenue up 10% to $10.55 billion and net profit after tax rising 5.4% to $462.4 million. The company declared a fully franked final dividend and a special dividend, while announcing a CEO succession plan.
Logan Eniac
Logan Eniac
11 Aug 2025
PEXA Group has initiated a strategic review of its Digital Solutions business, signaling a shift in capital allocation and revising its FY25 impairment charge guidance significantly higher. The company also updates depreciation and tax expense forecasts ahead of its full-year results.
Sophie Babbage
Sophie Babbage
11 Aug 2025
JB Hi-Fi announces a seamless leadership transition with Nick Wells set to succeed Terry Smart as Group CEO in October 2025, underscoring strong succession planning and continuity.
Logan Eniac
Logan Eniac
11 Aug 2025
CAR Group Limited has reported solid full-year FY25 results with revenue surpassing AUD 1.18 billion and adjusted NPAT rising to AUD 377 million, underpinned by global marketplace strength and strategic innovation. The company projects continued double-digit growth in FY26, driven by technology investments and market expansion.
Sophie Babbage
Sophie Babbage
11 Aug 2025
CAR Group Limited has reported strong FY25 financial results with double-digit revenue and earnings growth across all key markets, while preparing for a leadership change. The company’s optimistic FY26 outlook underscores confidence in sustained expansion driven by innovation and market leadership.
Sophie Babbage
Sophie Babbage
11 Aug 2025
CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.
Sophie Babbage
Sophie Babbage
11 Aug 2025
Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.
Ada Torres
Ada Torres
11 Aug 2025
AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.
Ada Torres
Ada Torres
8 Aug 2025
Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.
Victor Sage
Victor Sage
8 Aug 2025
Vection Technologies has reported its first positive underlying EBITDA for FY2025, driven by strong growth in its Defence sector. The company sets ambitious FY2026 revenue targets of $70 million, underpinned by a robust $50 million sales pipeline and cutting-edge AI and spatial computing solutions.
Sophie Babbage
Sophie Babbage
8 Aug 2025
AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.
Ada Torres
Ada Torres
8 Aug 2025